Syndax Pharmaceuticals

$9.17
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.58 (-5.95%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell SNDX and other stocks, options, ETFs, and crypto commission-free!

About SNDX

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include candidate and entinostat. Read More The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.

Employees
38
Headquarters
Waltham, Massachusetts
Founded
2005
Market Cap
248.85M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
167.96K
High Today
$9.76
Low Today
$9.10
Open Price
$9.71
Volume
95.48K
52 Week High
$11.11
52 Week Low
$3.39

Collections

SNDX News

ReutersAug 10

Edited Transcript of SNDX earnings conference call or presentation 7-Aug-19 8:30pm GMT

3

SNDX Earnings

-$0.96
-$0.78
-$0.61
-$0.43
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 5, After Hours

More SNDX News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.